This approach is highly significant in the fields of drug design, structural biology, and chemoinformatics.This study integrates traditional Chinese medicine with the clinical use of Chinese herbal medicine for Crohn’s disease and colon cancer, such as Coptis chinensis (Huang Lian), Phellodendron amurense (Huang Bai), and Sanguisorba officinalis (Di Yu), and has identified relevant active substances including Luteolin (MOL000006), Apigenin (MOL000008), Berberine (MOL001454), Palmatine (MOL001458), 6-Gingerol (MOL002467), Sanguisorba saponin I (MOL006557), and punicalagin (MOL009146).
← all excerpts
Analysis of diagnostic genes and molecular mechanisms of Crohn's disease and colon cancer based on machine learning algorithms.
1
—
—